View Future GrowthBATM Advanced Communications 과거 순이익 실적과거 기준 점검 0/6BATM Advanced Communications 의 수입은 연평균 -76.9%의 비율로 감소해 온 반면, Communications 산업은 연평균 0.9%의 비율로 감소했습니다. 매출은 연평균 8.5%의 비율로 감소해 왔습니다.핵심 정보-76.86%순이익 성장률-76.86%주당순이익(EPS) 성장률Communications 산업 성장률31.77%매출 성장률-8.51%자기자본이익률-19.89%순이익률-9.89%최근 순이익 업데이트31 Dec 2025최근 과거 실적 업데이트공시 • Jul 24BATM Advanced Communications Ltd. to Report First Half, 2025 Results on Aug 18, 2025BATM Advanced Communications Ltd. announced that they will report first half, 2025 results on Aug 18, 2025공시 • Mar 05BATM Advanced Communications Ltd. to Report Fiscal Year 2024 Results on Mar 17, 2025BATM Advanced Communications Ltd. announced that they will report fiscal year 2024 results on Mar 17, 2025공시 • Feb 29BATM Advanced Communications Ltd. to Report Fiscal Year 2023 Results on Mar 12, 2024BATM Advanced Communications Ltd. announced that they will report fiscal year 2023 results on Mar 12, 2024모든 업데이트 보기Recent updates공시 • Nov 06BATM Advanced Communications Ltd., Annual General Meeting, Dec 10, 2025BATM Advanced Communications Ltd., Annual General Meeting, Dec 10, 2025. Location: the groups registered office, 4 ha harash street, nave ne eman industrial area, p o b 7318, 4524075 hod hasharon, Israel공시 • Oct 08Zvi Marom entered into an agreement to acquire A.M.S. 2000 Trading Impex S.r.l from BATM Advanced Communications Ltd. (LSE:BVC) for £17.6 million.DR.Zvi Marom entered into an agreement to acquire A.M.S. 2000 Trading Impex S.r.l from BATM Advanced Communications Ltd. (LSE:BVC) for £17.6 million on October 6, 2025. Under the terms of the Sale Agreement, the Group will sell AMS to Dr. Zvi Marom, a non-executive director and significant shareholder of the Group, in exchange for his entire shareholding of 96,794,500 ordinary shares of in BATM, representing c. 22.2% of the existing issued share capital. The transaction values AMS at £17.6m, based on the closing price of the Group's Ordinary Shares. Following completion, Dr. Marom will cease to be a shareholder of the Group and will resign as a director of the Group. The completion of the sale is subject to the approval of shareholders at a general meeting and and all other legal and regulatory requirements; the Board will issue a circular to convene this general meeting in due course. Mark Percy, Anita Ghanekar, James Thomas acted as advisor to BATM Advanced Communications.공시 • Sep 27BATM Advanced Communications Ltd. Announces Board and Committee ChangesBATM Advanced Communications Ltd. announced that Harel Locker is retiring from his position as an external director, as defined under Israeli law, of the Group with immediate effect. Mr. Locker completes his third three-year term as an external director of BATM. External directors under Israeli law are appointed for a minimum of one three-year term, which may be extended by the company (subject to shareholder approval) for no more than two additional terms of three years each. The Board will propose the appointment of a new external director for approval by shareholders at the Group's next annual general meeting. Following Mr. Locker's retirement from the Board, Prof. Varda Shalev, an external director of BATM, will assume the role of Interim Chair of the Audit Committee and a permanent chair will be appointed in due course.공시 • Jul 24BATM Advanced Communications Ltd. to Report First Half, 2025 Results on Aug 18, 2025BATM Advanced Communications Ltd. announced that they will report first half, 2025 results on Aug 18, 2025공시 • Jun 23+ 1 more updateBATM Advanced Communications Ltd. announces resignation of Ran Noy as Director, Effective 23 June 2025BATM Advanced Communications Ltd. announced that Ran Noy has resigned as Chief Financial Officer and a Director of the Group, effective 23 June 2025.공시 • Mar 05BATM Advanced Communications Ltd. to Report Fiscal Year 2024 Results on Mar 17, 2025BATM Advanced Communications Ltd. announced that they will report fiscal year 2024 results on Mar 17, 2025공시 • Dec 19BATM Approves the Appointment of Shmuel Ben Zvi as Non-Executive Director of the GroupBATM at its Annual General Meeting held on 19 December 2024, approved the appointment of Dr. Shmuel (Muli) Ben Zvi as a Non-executive Director of the Group with effect from the conclusion of the Meeting.공시 • Dec 12BATM Advanced Communications Limited Announces Commencement of Natslab Molecular Biology PlatformBATM Advanced Communications Limited announced that the NATlab molecular biology platform being developed by ADOR Diagnostics ("ADOR"), an associate company of the Group, has commenced pre-clinical validation at the Lazzaro Spallanzani National Institute for Infectious Diseases in Rome, Italy. This marks a key milestone in the development of NATlab and, the Group believes, will enable initial sales as well as increase industry awareness and interest from prospective partners. The advanced NATlab molecular biology platform is a point-of-care sample-to-answer solution designed to provide rapid and accurate diagnosis of infectious disease. It uses a patented isothermal amplification method for syndromic multiplex diagnostics to be able to rapidly identify a broad range of pathogens from a single test. The commencement of the pre-clinical validation phase follows the successful completion of pre-clinical trials, which were conducted at the Tzafom Medical Center in Israel, to confirm the validity of the biological process that ADOR has developed and that it can be performed within the NATlab cartridge and analyser device. NATlab identified all negative samples and had a 97% sensitivity for the positive samples, confirming the efficacy of the system and its ability to out-perform competing solutions available in the market because of its multiplex diagnostic capability for rapid and accurate diagnosis. ADOR has now made significant progress with NATlab with the full system entering the pre-clinical validation phase at the Lazzaro Sp allanzani National Institute forinfectious Diseases in Rome, a leading centre for infectious disease research and treatment. Successful completion of the pre-clinical validation is expected to enable initial sales of the NATlab and the commencement of the regulatory process under the European Union In Vitro Diagnostic Medical Device Regulation to become eligible for sale in the EU market. In addition, following the success of the pre-clinical trials, ADOR, in collaboration with the Tzafom Medical center, has received a grant from the Israel Innovation Authority to develop a NATlab panel for the diagnosis of stomach ulcers. The total value is NIS 3.4 million (c. $1 million), which is to be granted over two years based on the achievement of milestones.공시 • Nov 15BATM Advanced Communications Ltd., Annual General Meeting, Dec 19, 2024BATM Advanced Communications Ltd., Annual General Meeting, Dec 19, 2024. Location: the groups registered office, 4 ha harash street, nave ne eman industrial area, p o b 7318, 4524075 hod hasharon, Israel공시 • Aug 19BATM Advanced Communications Ltd. Provides Earnings Guidance for the Second Half of 2024BATM Advanced Communications Ltd. provided earnings guidance for the second half of 2024. For the period, the company expects increase in revenue.공시 • May 03BATM Advanced Communications Ltd. Selected for Tb Diagnostics ProgrammeBATM announce that the Group has been selected for aprestigious programme, that is receiving funding from the European Union, for the development of an advanced tuberculosis ("TB") diagnostics solution. The Group has also been awarded a grant of €0.5 million towards the initial 18 months of the programme with the potential for additional funding to be awarded thereafter for the next stage. The Group was selected by the National Research Council of Italy (Consiglio Nazionale delle Ricerche) ("CNR") under a competitive process involving many companies and after a lengthy and detailed verification phase to participate in the programme alongside one of CNR's research institutes, the Institute for System Analysis and Computer Science (Istituto di Analisi dei Sistemi ed Informatica) ("IASI"). The Group's participation reflects its strategy to advance the BATM diagnostics division through developing advanced molecular diagnostics solutions for substantial infectious disease markets, with the global diagnostics market for TB being worth over $2 billion. It is also demonstrative of the steps that the Group is taking to drive long-term sustainable growth through investing in constant innovation to maintain the diagnostics division's technological edge. The programme is for the development of a diagnostics system, based on the Rolling Circle Amplification ("RCA") method, for the rapid identification of TB and multi-drug resistant TB. This builds on the existing work of the BATM diagnostics division for the development of a rapid, RCA-based sample-to-answer diagnostic solution for TB and multi-drug resistant TB. The programme is receiving funding from the European Regional Development Fund via the Lazio Regional Operational Program of the Lazio regional government.공시 • Feb 29BATM Advanced Communications Ltd. to Report Fiscal Year 2023 Results on Mar 12, 2024BATM Advanced Communications Ltd. announced that they will report fiscal year 2023 results on Mar 12, 2024매출 및 비용 세부 내역BATM Advanced Communications가 돈을 벌고 사용하는 방법. 최근 발표된 LTM 실적 기준.순이익 및 매출 추이OTCPK:BVCL.F 매출, 비용 및 순이익 (USD Millions)날짜매출순이익일반관리비연구개발비31 Dec 25123-1234530 Sep 25121-1034530 Jun 25119-834531 Mar 25118-833531 Dec 24117-732530 Jun 24115331331 Mar 24116231431 Dec 23117132430 Sep 23121034630 Jun 23119034731 Mar 23117032731 Dec 22116030730 Sep 22121130830 Jun 22126329831 Mar 22133830931 Dec 211401431930 Sep 211591733930 Jun 2117820351031 Mar 2118115351031 Dec 2018410361030 Sep 20164733930 Jun 20145531731 Mar 20134429731 Dec 19123428730 Sep 19120328730 Jun 19118227731 Mar 19119127731 Dec 18120027730 Sep 18118127730 Jun 18116126831 Mar 18111126831 Dec 17107025830 Sep 17101-125830 Jun 1795-324831 Mar 1793-224831 Dec 1690-124830 Sep 1693-724730 Jun 1695-1324731 Mar 1696-1324731 Dec 1597-1324730 Sep 1599-924730 Jun 15100-5257양질의 수익: BVCL.F 은(는) 현재 수익성이 없습니다.이익 마진 증가: BVCL.F는 현재 수익성이 없습니다.잉여현금흐름 대비 순이익 분석과거 순이익 성장 분석수익추이: BVCL.F은 수익성이 없으며 지난 5년 동안 손실이 연평균 76.9% 증가했습니다.성장 가속화: 현재 수익성이 없어 지난 1년간 BVCL.F의 수익 성장률을 5년 평균과 비교할 수 없습니다.수익 대 산업: BVCL.F은 수익성이 없어 지난 해 수익 성장률을 Communications 업계(11.5%)와 비교하기 어렵습니다.자기자본이익률높은 ROE: BVCL.F는 현재 수익성이 없으므로 자본 수익률이 음수(-19.89%)입니다.총자산이익률투하자본수익률우수한 과거 실적 기업을 찾아보세요7D1Y7D1Y7D1YTech 산업에서 과거 실적이 우수한 기업.View Financial Health기업 분석 및 재무 데이터 상태데이터최종 업데이트 (UTC 시간)기업 분석2026/05/25 08:44종가2026/02/25 00:00수익2025/12/31연간 수익2025/12/31데이터 소스당사의 기업 분석에 사용되는 데이터는 S&P Global Market Intelligence LLC에서 제공됩니다. 아래 데이터는 이 보고서를 생성하기 위해 분석 모델에서 사용됩니다. 데이터는 정규화되므로 소스가 제공된 후 지연이 발생할 수 있습니다.패키지데이터기간미국 소스 예시 *기업 재무제표10년손익계산서현금흐름표대차대조표SEC 양식 10-KSEC 양식 10-Q분석가 컨센서스 추정치+3년재무 예측분석가 목표주가분석가 리서치 보고서Blue Matrix시장 가격30년주가배당, 분할 및 기타 조치ICE 시장 데이터SEC 양식 S-1지분 구조10년주요 주주내부자 거래SEC 양식 4SEC 양식 13D경영진10년리더십 팀이사회SEC 양식 10-KSEC 양식 DEF 14A주요 개발10년회사 공시SEC 양식 8-K* 미국 증권에 대한 예시이며, 비(非)미국 증권에는 해당 국가의 규제 서식 및 자료원을 사용합니다.별도로 명시되지 않는 한 모든 재무 데이터는 연간 기간을 기준으로 하지만 분기별로 업데이트됩니다. 이를 TTM(최근 12개월) 또는 LTM(지난 12개월) 데이터라고 합니다. 자세히 알아보기.분석 모델 및 스노우플레이크이 보고서를 생성하는 데 사용된 분석 모델에 대한 세부 정보는 당사의 Github 페이지에서 확인하실 수 있으며, 보고서 활용 방법에 대한 가이드와 YouTube 튜토리얼도 제공하고 있습니다.Simply Wall St 분석 모델을 설계하고 구축한 세계적 수준의 팀에 대해 알아보세요.산업 및 섹터 지표산업 및 섹터 지표는 Simply Wall St가 6시간마다 계산하며, 프로세스에 대한 자세한 내용은 Github에서 확인할 수 있습니다.분석가 소스BATM Advanced Communications Ltd.는 4명의 분석가가 다루고 있습니다. 이 중 1명의 분석가가 우리 보고서에 입력 데이터로 사용되는 매출 또는 수익 추정치를 제출했습니다. 분석가의 제출 자료는 하루 종일 업데이트됩니다.분석가기관null nullCavendishSimon StrongPeel Hunt LLPAlasdair YoungShore Capital Group Ltd1명의 분석가 더 보기
공시 • Jul 24BATM Advanced Communications Ltd. to Report First Half, 2025 Results on Aug 18, 2025BATM Advanced Communications Ltd. announced that they will report first half, 2025 results on Aug 18, 2025
공시 • Mar 05BATM Advanced Communications Ltd. to Report Fiscal Year 2024 Results on Mar 17, 2025BATM Advanced Communications Ltd. announced that they will report fiscal year 2024 results on Mar 17, 2025
공시 • Feb 29BATM Advanced Communications Ltd. to Report Fiscal Year 2023 Results on Mar 12, 2024BATM Advanced Communications Ltd. announced that they will report fiscal year 2023 results on Mar 12, 2024
공시 • Nov 06BATM Advanced Communications Ltd., Annual General Meeting, Dec 10, 2025BATM Advanced Communications Ltd., Annual General Meeting, Dec 10, 2025. Location: the groups registered office, 4 ha harash street, nave ne eman industrial area, p o b 7318, 4524075 hod hasharon, Israel
공시 • Oct 08Zvi Marom entered into an agreement to acquire A.M.S. 2000 Trading Impex S.r.l from BATM Advanced Communications Ltd. (LSE:BVC) for £17.6 million.DR.Zvi Marom entered into an agreement to acquire A.M.S. 2000 Trading Impex S.r.l from BATM Advanced Communications Ltd. (LSE:BVC) for £17.6 million on October 6, 2025. Under the terms of the Sale Agreement, the Group will sell AMS to Dr. Zvi Marom, a non-executive director and significant shareholder of the Group, in exchange for his entire shareholding of 96,794,500 ordinary shares of in BATM, representing c. 22.2% of the existing issued share capital. The transaction values AMS at £17.6m, based on the closing price of the Group's Ordinary Shares. Following completion, Dr. Marom will cease to be a shareholder of the Group and will resign as a director of the Group. The completion of the sale is subject to the approval of shareholders at a general meeting and and all other legal and regulatory requirements; the Board will issue a circular to convene this general meeting in due course. Mark Percy, Anita Ghanekar, James Thomas acted as advisor to BATM Advanced Communications.
공시 • Sep 27BATM Advanced Communications Ltd. Announces Board and Committee ChangesBATM Advanced Communications Ltd. announced that Harel Locker is retiring from his position as an external director, as defined under Israeli law, of the Group with immediate effect. Mr. Locker completes his third three-year term as an external director of BATM. External directors under Israeli law are appointed for a minimum of one three-year term, which may be extended by the company (subject to shareholder approval) for no more than two additional terms of three years each. The Board will propose the appointment of a new external director for approval by shareholders at the Group's next annual general meeting. Following Mr. Locker's retirement from the Board, Prof. Varda Shalev, an external director of BATM, will assume the role of Interim Chair of the Audit Committee and a permanent chair will be appointed in due course.
공시 • Jul 24BATM Advanced Communications Ltd. to Report First Half, 2025 Results on Aug 18, 2025BATM Advanced Communications Ltd. announced that they will report first half, 2025 results on Aug 18, 2025
공시 • Jun 23+ 1 more updateBATM Advanced Communications Ltd. announces resignation of Ran Noy as Director, Effective 23 June 2025BATM Advanced Communications Ltd. announced that Ran Noy has resigned as Chief Financial Officer and a Director of the Group, effective 23 June 2025.
공시 • Mar 05BATM Advanced Communications Ltd. to Report Fiscal Year 2024 Results on Mar 17, 2025BATM Advanced Communications Ltd. announced that they will report fiscal year 2024 results on Mar 17, 2025
공시 • Dec 19BATM Approves the Appointment of Shmuel Ben Zvi as Non-Executive Director of the GroupBATM at its Annual General Meeting held on 19 December 2024, approved the appointment of Dr. Shmuel (Muli) Ben Zvi as a Non-executive Director of the Group with effect from the conclusion of the Meeting.
공시 • Dec 12BATM Advanced Communications Limited Announces Commencement of Natslab Molecular Biology PlatformBATM Advanced Communications Limited announced that the NATlab molecular biology platform being developed by ADOR Diagnostics ("ADOR"), an associate company of the Group, has commenced pre-clinical validation at the Lazzaro Spallanzani National Institute for Infectious Diseases in Rome, Italy. This marks a key milestone in the development of NATlab and, the Group believes, will enable initial sales as well as increase industry awareness and interest from prospective partners. The advanced NATlab molecular biology platform is a point-of-care sample-to-answer solution designed to provide rapid and accurate diagnosis of infectious disease. It uses a patented isothermal amplification method for syndromic multiplex diagnostics to be able to rapidly identify a broad range of pathogens from a single test. The commencement of the pre-clinical validation phase follows the successful completion of pre-clinical trials, which were conducted at the Tzafom Medical Center in Israel, to confirm the validity of the biological process that ADOR has developed and that it can be performed within the NATlab cartridge and analyser device. NATlab identified all negative samples and had a 97% sensitivity for the positive samples, confirming the efficacy of the system and its ability to out-perform competing solutions available in the market because of its multiplex diagnostic capability for rapid and accurate diagnosis. ADOR has now made significant progress with NATlab with the full system entering the pre-clinical validation phase at the Lazzaro Sp allanzani National Institute forinfectious Diseases in Rome, a leading centre for infectious disease research and treatment. Successful completion of the pre-clinical validation is expected to enable initial sales of the NATlab and the commencement of the regulatory process under the European Union In Vitro Diagnostic Medical Device Regulation to become eligible for sale in the EU market. In addition, following the success of the pre-clinical trials, ADOR, in collaboration with the Tzafom Medical center, has received a grant from the Israel Innovation Authority to develop a NATlab panel for the diagnosis of stomach ulcers. The total value is NIS 3.4 million (c. $1 million), which is to be granted over two years based on the achievement of milestones.
공시 • Nov 15BATM Advanced Communications Ltd., Annual General Meeting, Dec 19, 2024BATM Advanced Communications Ltd., Annual General Meeting, Dec 19, 2024. Location: the groups registered office, 4 ha harash street, nave ne eman industrial area, p o b 7318, 4524075 hod hasharon, Israel
공시 • Aug 19BATM Advanced Communications Ltd. Provides Earnings Guidance for the Second Half of 2024BATM Advanced Communications Ltd. provided earnings guidance for the second half of 2024. For the period, the company expects increase in revenue.
공시 • May 03BATM Advanced Communications Ltd. Selected for Tb Diagnostics ProgrammeBATM announce that the Group has been selected for aprestigious programme, that is receiving funding from the European Union, for the development of an advanced tuberculosis ("TB") diagnostics solution. The Group has also been awarded a grant of €0.5 million towards the initial 18 months of the programme with the potential for additional funding to be awarded thereafter for the next stage. The Group was selected by the National Research Council of Italy (Consiglio Nazionale delle Ricerche) ("CNR") under a competitive process involving many companies and after a lengthy and detailed verification phase to participate in the programme alongside one of CNR's research institutes, the Institute for System Analysis and Computer Science (Istituto di Analisi dei Sistemi ed Informatica) ("IASI"). The Group's participation reflects its strategy to advance the BATM diagnostics division through developing advanced molecular diagnostics solutions for substantial infectious disease markets, with the global diagnostics market for TB being worth over $2 billion. It is also demonstrative of the steps that the Group is taking to drive long-term sustainable growth through investing in constant innovation to maintain the diagnostics division's technological edge. The programme is for the development of a diagnostics system, based on the Rolling Circle Amplification ("RCA") method, for the rapid identification of TB and multi-drug resistant TB. This builds on the existing work of the BATM diagnostics division for the development of a rapid, RCA-based sample-to-answer diagnostic solution for TB and multi-drug resistant TB. The programme is receiving funding from the European Regional Development Fund via the Lazio Regional Operational Program of the Lazio regional government.
공시 • Feb 29BATM Advanced Communications Ltd. to Report Fiscal Year 2023 Results on Mar 12, 2024BATM Advanced Communications Ltd. announced that they will report fiscal year 2023 results on Mar 12, 2024